GlassScriptPhysician profile
Cody S Freeman
NPI 1659719862
$7,714.52
in general payments reported to CMS, 2019-2025
46 companies · $178 in 2025
The $178 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $750 · 2020: $482 · 2021: $1,376 · 2022: $2,317 · 2023: $2,488 · 2024: $125 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,513 · Education: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,512.90 |
| Education | $277.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $1,337.38 | 2019-2023 | Austedo Xr, Austedo |
| Abbvie INC. | $1,029.89 | 2021-2025 | |
| Acadia Pharmaceuticals INC | $861.94 | 2019-2023 | Nuplazid |
| Neurocrine Biosciences, INC. | $776.20 | 2021-2023 | Ingrezza, Ongentys |
| Biohaven Pharmaceuticals, INC. | $740.96 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $560.34 | 2022 | |
| Boston Scientific Corporation | $279.81 | 2019 | |
| Kyowa Kirin, INC. | $208.77 | 2019-2023 | Nourianz |
| Eisai INC. | $148.00 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $141.93 | 2019-2022 | |
| Noctrix Health, INC. | $104.91 | 2025 | Nidra |
| Acorda Therapeutics, INC | $102.58 | 2019-2023 | Inbrija |
| Amgen INC. | $99.59 | 2019-2023 | Aimovig |
| Argenx US, INC. | $95.16 | 2022-2023 | Vyvgart Hytrulo, Vyvgart |
| Pfizer INC. | $88.56 | 2023 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cody Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.